Healthcare Industry News: Thermage
News Release - August 3, 2006
Stephen J. Fanning Elected Chairman of the Board of ThermageHAYWARD, Calif., Aug. 3 (HSMN NewsFeed) -- Thermage, Inc., a leading medical device company that manufactures and markets non-invasive treatments to tighten and contour skin, announced today that Stephen J. Fanning, 55, has been elected Chairman by the Board of Directors. Mr. Fanning joined Thermage in January 2005 as President, CEO and a Member of the Board and will continue to serve as President and CEO. He replaces Samuel D. Colella, who has served as Chairman since February 2005. Mr. Colella will remain on the Board as a Director.
"The Board is delighted to recognize Steve's invaluable contribution since he joined the Company in early 2005," said Mr. Colella. "Steve has been instrumental in leading Thermage through significant challenges and building a best-of-class organization. Under his leadership, the Company has built strong relationships with doctors, significantly expanding the Company's international presence and achieving very high levels of consumer awareness. At the same time, Steve implemented strategies that emphasized Thermage's leadership and commitment to both consumer education and safety. Since his arrival, he has dedicated himself to building a global team and operations that set the standard of excellence in our industry. The entire Board looks forward to working with Steve as he leads the Company to its next phase of growth," Mr. Colella added.
"I am honored by the Board's confidence," stated Mr. Fanning. "Our entire organization has played a role in our significant success during 2006. We've launched new products and are poised to launch more during the remainder of the year and in 2007. I look forward to working with both the Board and our management team to further build Thermage in the years ahead."
Mr. Fanning was appointed President and CEO of Thermage on January 15, 2005. Most recently, Mr. Fanning served as President and CEO for Ocular Sciences, Inc., a $350 million global public Company, which developed, manufactured and marketed disposable contact lenses. Under his leadership, Ocular Sciences was sold to CooperVision for $1.3 billion in January 2005. Prior to joining Ocular Sciences, Mr. Fanning served in various senior executive positions for 25 years at Johnson & Johnson.
Thermage is a leading medical device company developing innovative aesthetic technologies, including its patented capacitive radiofrequency device, to achieve a desired cosmetic or therapeutic effect on and under the skin surface. Its flagship ThermaCool system received FDA clearance for full- face treatment in June 2004, adding to the clearance obtained in November 2002 for treatment of periorbital wrinkles and rhytids. The device is currently installed in more than 1,200 dermatology, plastic surgery and other cosmetic surgery practices worldwide.
Founded in 1996, the Company's headquarters are located in Hayward, California, proximate to the San Francisco Bay Area and the Silicon Valley.
For more information about Thermage and its ThermaCool system, or to locate physicians using its exclusive radiofrequency technology, log on to www.Thermage.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.